Latest news with #Karima
India.com
05-07-2025
- Entertainment
- India.com
Meet famous actress whose debut film was a superhit, but delivered 5 back-to-back flops after it, even Salman Khan couldn't save it, actress is.., films are…
Meet famous actress whose debut film was a superhit, but delivered 5 back-to-back flops after it, even Salman Khan couldn't save it, actress is.., films are... In the unpredictable world of Bollywood, success is always fleeting. Sometimes, an actor who would be trying their luck in the industry wouldn't get commercial success that easily; however, sometimes a debutant becomes a viral sensation out of nowhere. The formula of stardom success remains unresolved in this industry. One such similar tale is of a celebrated actress who captivated the audience right from her debut. However, after claiming commercial and critical success, she saw a series of disappointments. The actress that we are talking about is none other than Karisma Kapoor. She made her debut with the film Prem Qaidi in 1991. The film turned out to be a blockbuster, and Karima's charm and strong screen presence won the hearts of the audience. However, after this major success, she delivered 5 consecutive flops. Police Officer Her second film was Police Officer. It was released on 5 June 1992, where she starred opposite Jackie Shroff. Jackie and Karima have an age difference of almost 2 decades. The chemistry of this pair didn't sit well with the audience, and the weak storyline also didn't quite strike a chord with the audience, therefore leading to its failure. Jagriti Later on 3 July 1992, Karima came in the film Jagriti opposite the blockbuster star, Salman Khan. Despite Salman's major fan following, this film left the audience disappointed, marking as the second failure in Karisma's career since her debut. Nishchay 14 days after Jagriti, another Karisma-Salman film titled Nishchay was released. This film was a romantic drama, and the audience had high hopes for the duo; however, it also couldn't make a mark and turned out to be the third flop for Karisma. Sapne Sajan Ke A week after that, Karisma's film Sapne Sajan Ke came out in 1992. The film starred her with Rahul Roy, Jackie Shroff, Gulshan Grover, Reema Lagoo, and Alok Nath. Even after this star-studded cast, this film left the audience feeling unfulfilled. Deedar Her next flop was Deedar, where she starred opposite Akshay Kumar. This was the first film of the duo together; however, it also couldn't resonate with the audience. Today, Karisma Kapoor is known as a celebrated actress. Despite her consecutive flops in her early years, she went on to carve a niche for herself and turned out to be a successful actress,
Express Tribune
01-07-2025
- Business
- Express Tribune
Wimbledon's top strawberry faces juicy competition
Malling Centenary is known for its sweetness and size. Photo: Reuters It may be the top seed at Wimbledon but even the reigning king of strawberries knows the crown sits lightly. The Malling Centenary berry has reigned supreme since being introduced at The Championships in 2016, sweetening summer rituals and picnics alike at the All England Club. Yet in the fields and labs, a new crop of challengers is ripening. In the high-stakes world of soft fruit supremacy, flavour, firmness and fame are all up for grabs. The Malling Centenary variety is known for its sweetness, "heart-shaped" size, and quality of taste, according to Joe Furber, Food and Drinks Operations Manager at Wimbledon. Weeks of sunshine and a "bumper crop" in the UK have helped produce an excess of strawberries, meaning Furber expects around 2.5 million of them, or 5,000 tonnes, alongside 13,000 litres of cream to be consumed during the Wimbledon fortnight. This year, a portion of 10 Malling Centenary strawberries with cream costs two pounds and seventy pence after the first price increase (20 pence) since 2010. The strawberries are grown in polytunnels by Hugh Lowe Farms, a family-owned business in Kent, just 31 miles from the All England Club, picked and delivered each morning at 8.30am. "Their best time aligns perfectly with the championships, which is quite fortuitous, which is a big part of why they were chosen," Furber said. But like every champion, it cannot afford to rest on its laurels as contenders lurk to seize the strawberry crown. The Summer Berry Company, based at Groves Farm near Chichester, told Reuters the variety landscape is becoming increasingly competitive and that it has reduced its production of Malling Centenary over the years. "I love Malling Centenary, I'm in no way saying it's a bad variety. I'm just saying that there's a new generation of varieties we're bringing to the market," commercial director Jack Darnes said. Summer Berry, which uses robotics and artificial intelligence technology to help with the harvesting process, grows varieties including Fandango, Karima and Florice, which Darnes said are larger and sweeter. "With Malling Centenary three or four days later they're still okay, with the new varieties you can survive even longer — six to seven days. So it's reducing waste, it's a better product for the end consumer," he said. "We hope one day there's going to be a new summer berry variety that people at Wimbledon are going to be consuming even better than Malling Centenary." The UK produces 120,000 tonnes of strawberries each year, generating retail sales of up to 700 million pounds, said Darnes.
Straits Times
30-06-2025
- Sport
- Straits Times
Wimbledon's strawberry champion faces rivals for its crown
Tennis - Wimbledon - All England Lawn Tennis and Croquet Club, London, Britain - June 30, 2025 A spectator holds a box of strawberries and creams at Wimbledon REUTERS/Toby Melville Tennis - Wimbledon - All England Lawn Tennis and Croquet Club, London, Britain - June 30, 2025 Punnets of strawberries ahead of day one of Wimbledon REUTERS/Andrew Couldridge Tennis - Wimbledon - All England Lawn Tennis and Croquet Club, London, Britain - June 30, 2025 A member of the catering staff carries a box of strawberries for sale at Wimbledon REUTERS/Toby Melville Tennis - Wimbledon - All England Lawn Tennis and Croquet Club, London, Britain - June 30, 2025 Boxes and punnets of strawberries are seen in the ground ahead of day one of Wimbledon REUTERS/Toby Melville TPX IMAGES OF THE DAY LONDON - It may be the top seed at Wimbledon but even the reigning king of strawberries knows the crown sits lightly. The Malling Centenary berry has reigned supreme since being introduced at The Championships in 2016, sweetening summer rituals and picnics alike at the All England Club. Yet in the fields and labs, a new crop of challengers is ripening. In the high-stakes world of soft fruit supremacy, flavour, firmness and fame are all up for grabs. The Malling Centenary variety is known for its sweetness, 'heart-shaped' size, and quality of taste, according to Joe Furber, Food and Drinks Operations Manager at Wimbledon. Weeks of sunshine and a "bumper crop" in the UK have helped produce an excess of strawberries, meaning Furber expects around 2.5 million of them, or 5,000 tonnes, alongside 13,000 litres of cream to be consumed during the Wimbledon fortnight. This year, a portion of 10 Malling Centenary strawberries with cream costs two pounds and seventy pence ($3.70) after the first price increase (20 pence) since 2010. The strawberries are grown in polytunnels by Hugh Lowe Farms, a family-owned business in Kent, just 31 miles from the All England Club, picked and delivered each morning at 8:30am. 'Their best time aligns perfectly with the championships, which is quite fortuitous, which is a big part of why they were chosen,' Furber said. But like every champion, it cannot afford to rest on its laurels as contenders lurk to seize the strawberry crown. The Summer Berry Company, based at Groves Farm near Chichester, told Reuters the variety landscape is becoming increasingly competitive and that it has reduced its production of Malling Centenary over the years. 'I love Malling Centenary, I'm in no way saying it's a bad variety. I'm just saying that there's a new generation of varieties we're bringing to the market,' Commercial Director Jack Darnes said. Summer Berry, which uses robotics and artificial intelligence technology to help with the harvesting process, grows varieties including Fandango, Karima and Florice, which Darnes said are larger and sweeter. 'With Malling Centenary three or four days later they're still okay, with the new varieties you can survive even longer - six to seven days. So it's reducing waste, it's a better product for the end consumer,' he said. 'We hope one day there's going to be a new summer berry variety that people at Wimbledon are going to be consuming even better than Malling Centenary,' he added. Malling Centenary does not suffer the same fate as its predecessor, the Elsanta Variety, which, according to Darnes, is no longer produced in the UK. The UK produces 120,000 tonnes of strawberries each year, generating retail sales of up to 700 million pounds, said Darnes. The global market is estimated at about 10,000,000 tonnes, with a value of $20 billion, according to German agriculture company Bayer. REUTERS Join ST's Telegram channel and get the latest breaking news delivered to you.
Malaysian Reserve
02-05-2025
- Business
- Malaysian Reserve
Strategic Accounts, to strengthen global client partnerships
The industry veteran brings over 25 years of healthcare marketing expertise in accelerating growth and value for leading pharmaceutical brands SHORT HILLS, N.J., May 1, 2025 /PRNewswire/ — Doceree, the world's first global network of physician-only platforms for programmatic messaging, announces the appointment of Karima Sharif as Senior Vice President – Strategic Accounts this April. With over two decades of experience in healthcare media and marketing, Karima joins Doceree to strengthen its strategic partnerships and deliver scalable solutions for pharmaceutical brands and other partners, across its global markets. A powerhouse in healthcare marketing, Karima is known as the 'Fresh Princess of Media.' With an unmatched depth of experience across omnichannel strategy, multicultural and inclusive marketing, customer and data segmentation, and full-funnel media execution across both DTC and HCP audiences, she has helped shape the marketing journeys of 100+ pharmaceutical and medical device brands across various therapeutic categories. Her career is highlighted by the impact she's made at agencies such as CMI/WPP, Publicis and IPG MediaBrands, managing multi-million dollar paid media budgets. At Doceree, Karima will use her experience to drive growth, innovation, and value creation for the company's strategic accounts. Commenting on her new role, Karima Sharif, SVP – Strategic Accounts, Doceree, said, 'I'm thrilled to join Doceree at such a pivotal moment in its journey. The company is truly leading change in the healthcare ecosystem by redefining how pharma marketers engage with HCPs through data-driven, platform-first strategies. I look forward to contributing to this incredible mission and driving meaningful impact alongside a team that's shaping the future of healthcare marketing.' Karima's expertise in building and driving meaningful partnerships, while leading high-performing teams and championing diversity and inclusion conversations in the industry, has earned her accolades like In Vivo's 2022 Rising Leader in Healthcare and DTC Perspectives' 2022 Agency Vanguard Award. 'At Doceree, we are committed to elevating HCP-patient conversations by improving how pharmaceutical brands connect with healthcare professionals in the digital world,' said Kamya Elawadhi, Chief Client Officer, Doceree. 'Karima's deep expertise in media strategy, inclusive messaging, and full-funnel execution will be pivotal in driving stronger outcomes for our partners and enhancing the overall HCP engagement ecosystem.' Karima is a recognized industry leader, with her thoughts featured in Adweek, MM+M, and more, where she's led important conversations around innovation in healthcare marketing and the need for inclusive, equitable campaigns that resonate with diverse audiences. Her leadership also extends into advocacy, as the cofounder of the Women of Color Affinity Group and former Operating Board President, North America for the Healthcare Businesswomen's Association (HBA), and most recently she has mentored emerging women leaders. About Doceree: Leading the way in making HCP-patient conversations richer and more meaningful through patented responsive technology, Doceree addresses both current and emerging challenges for healthcare and life sciences organizations in HCP-patient engagement, particularly where digital and technological advancements play a crucial role. We leverage our patented technology to ensure that HCP-patient conversations and interactions are more meaningful, richer, and outcome-oriented. Learn more: Photo:
Yahoo
01-05-2025
- Business
- Yahoo
Doceree welcomes Karima Sharif as SVP - Strategic Accounts, to strengthen global client partnerships
The industry veteran brings over 25 years of healthcare marketing expertise in accelerating growth and value for leading pharmaceutical brands SHORT HILLS, N.J., May 1, 2025 /PRNewswire/ -- Doceree, the world's first global network of physician-only platforms for programmatic messaging, announces the appointment of Karima Sharif as Senior Vice President – Strategic Accounts this April. With over two decades of experience in healthcare media and marketing, Karima joins Doceree to strengthen its strategic partnerships and deliver scalable solutions for pharmaceutical brands and other partners, across its global markets. A powerhouse in healthcare marketing, Karima is known as the "Fresh Princess of Media." With an unmatched depth of experience across omnichannel strategy, multicultural and inclusive marketing, customer and data segmentation, and full-funnel media execution across both DTC and HCP audiences, she has helped shape the marketing journeys of 100+ pharmaceutical and medical device brands across various therapeutic categories. Her career is highlighted by the impact she's made at agencies such as CMI/WPP, Publicis and IPG MediaBrands, managing multi-million dollar paid media budgets. At Doceree, Karima will use her experience to drive growth, innovation, and value creation for the company's strategic accounts. Commenting on her new role, Karima Sharif, SVP – Strategic Accounts, Doceree, said, "I'm thrilled to join Doceree at such a pivotal moment in its journey. The company is truly leading change in the healthcare ecosystem by redefining how pharma marketers engage with HCPs through data-driven, platform-first strategies. I look forward to contributing to this incredible mission and driving meaningful impact alongside a team that's shaping the future of healthcare marketing." Karima's expertise in building and driving meaningful partnerships, while leading high-performing teams and championing diversity and inclusion conversations in the industry, has earned her accolades like In Vivo's 2022 Rising Leader in Healthcare and DTC Perspectives' 2022 Agency Vanguard Award. "At Doceree, we are committed to elevating HCP-patient conversations by improving how pharmaceutical brands connect with healthcare professionals in the digital world," said Kamya Elawadhi, Chief Client Officer, Doceree. "Karima's deep expertise in media strategy, inclusive messaging, and full-funnel execution will be pivotal in driving stronger outcomes for our partners and enhancing the overall HCP engagement ecosystem." Karima is a recognized industry leader, with her thoughts featured in Adweek, MM+M, and more, where she's led important conversations around innovation in healthcare marketing and the need for inclusive, equitable campaigns that resonate with diverse audiences. Her leadership also extends into advocacy, as the cofounder of the Women of Color Affinity Group and former Operating Board President, North America for the Healthcare Businesswomen's Association (HBA), and most recently she has mentored emerging women leaders. About Doceree: Leading the way in making HCP-patient conversations richer and more meaningful through patented responsive technology, Doceree addresses both current and emerging challenges for healthcare and life sciences organizations in HCP-patient engagement, particularly where digital and technological advancements play a crucial role. We leverage our patented technology to ensure that HCP-patient conversations and interactions are more meaningful, richer, and outcome-oriented. Learn more: Photo: View original content to download multimedia: SOURCE Doceree Inc. Sign in to access your portfolio
